Comments
The stock of RPG Life Sciences remained firm at Rs 69, up 0.3 per cent, despite the company having failed to get a nod from the German Government.
The company informed the BSE that the Ministry of Social and Family Affairs, Health and Consumer Protection, Hamburg, Germany did not grant EU GMP for the company's API facility at Navi Mumbai, Maharashtra, post their inspection citing certain deficiencies.
The company said that this move will have adverse impact on its export business. "The company has taken immediate remedial measures, and is reviewing all the issues raised by the said health authority and is working towards resolving them in a time-bound manner," RPG Life Sciences said in a statement to the exchange.
The company continues to hold a valid WHO GMP and TGA, Australia certification for its facilities, the statement added.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.